SynthesisMultiple sclerosis and related disorders2022

Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis.

Irene Schiavetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.